Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan

10-year follow-up of the phase 2 ECOG-ACRIN study E1499

M. R. Smith, F. Hong, H. Li, L. I. Gordon, R. D. Gascoyne, Elisabeth M. Paietta, R. H. Advani, A. Forero-Torres, S. J. Horning, B. S. Kahl

Research output: Contribution to journalLetter

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)517-519
Number of pages3
JournalLeukemia
Volume31
Issue number2
DOIs
StatePublished - Feb 1 2017

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan : 10-year follow-up of the phase 2 ECOG-ACRIN study E1499. / Smith, M. R.; Hong, F.; Li, H.; Gordon, L. I.; Gascoyne, R. D.; Paietta, Elisabeth M.; Advani, R. H.; Forero-Torres, A.; Horning, S. J.; Kahl, B. S.

In: Leukemia, Vol. 31, No. 2, 01.02.2017, p. 517-519.

Research output: Contribution to journalLetter

Smith, MR, Hong, F, Li, H, Gordon, LI, Gascoyne, RD, Paietta, EM, Advani, RH, Forero-Torres, A, Horning, SJ & Kahl, BS 2017, 'Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499', Leukemia, vol. 31, no. 2, pp. 517-519. https://doi.org/10.1038/leu.2016.305
Smith, M. R. ; Hong, F. ; Li, H. ; Gordon, L. I. ; Gascoyne, R. D. ; Paietta, Elisabeth M. ; Advani, R. H. ; Forero-Torres, A. ; Horning, S. J. ; Kahl, B. S. / Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan : 10-year follow-up of the phase 2 ECOG-ACRIN study E1499. In: Leukemia. 2017 ; Vol. 31, No. 2. pp. 517-519.
@article{61f1741cfe7c46149219d46c783f6739,
title = "Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499",
author = "Smith, {M. R.} and F. Hong and H. Li and Gordon, {L. I.} and Gascoyne, {R. D.} and Paietta, {Elisabeth M.} and Advani, {R. H.} and A. Forero-Torres and Horning, {S. J.} and Kahl, {B. S.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1038/leu.2016.305",
language = "English (US)",
volume = "31",
pages = "517--519",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan

T2 - 10-year follow-up of the phase 2 ECOG-ACRIN study E1499

AU - Smith, M. R.

AU - Hong, F.

AU - Li, H.

AU - Gordon, L. I.

AU - Gascoyne, R. D.

AU - Paietta, Elisabeth M.

AU - Advani, R. H.

AU - Forero-Torres, A.

AU - Horning, S. J.

AU - Kahl, B. S.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=84994691879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994691879&partnerID=8YFLogxK

U2 - 10.1038/leu.2016.305

DO - 10.1038/leu.2016.305

M3 - Letter

VL - 31

SP - 517

EP - 519

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 2

ER -